INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 342 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $328,000 | -33.6% | 4,082 | -55.1% | 0.02% | -40.0% |
Q4 2020 | $494,000 | +172.9% | 9,082 | 0.0% | 0.02% | +56.2% |
Q3 2020 | $181,000 | -5.2% | 9,082 | 0.0% | 0.02% | -5.9% |
Q2 2020 | $191,000 | +1810.0% | 9,082 | +1078.0% | 0.02% | +1600.0% |
Q1 2020 | $10,000 | -9.1% | 771 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $11,000 | +10.0% | 771 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $10,000 | -23.1% | 771 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $13,000 | 0.0% | 771 | 0.0% | 0.00% | -50.0% |
Q1 2019 | $13,000 | +550.0% | 771 | +375.9% | 0.00% | – |
Q4 2018 | $2,000 | -33.3% | 162 | 0.0% | 0.00% | – |
Q3 2018 | $3,000 | +50.0% | 162 | +102.5% | 0.00% | – |
Q2 2018 | $2,000 | 0.0% | 80 | 0.0% | 0.00% | – |
Q1 2018 | $2,000 | 0.0% | 80 | 0.0% | 0.00% | – |
Q4 2017 | $2,000 | 0.0% | 80 | 0.0% | 0.00% | – |
Q3 2017 | $2,000 | – | 80 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 744,160 | $54,078,000 | 5.79% |
Discovery Value Fund | 986,173 | $71,665,000 | 5.28% |
Ally Bridge Group (NY) LLC | 60,000 | $4,360,000 | 3.23% |
MPM BioImpact LLC | 159,409 | $11,584,000 | 3.11% |
ARK Investment Management | 8,981,029 | $652,651,000 | 2.72% |
Elmwood Wealth Management, Inc. | 67,599 | $4,912,000 | 2.52% |
Nikko Asset Management Americas, Inc. | 2,872,269 | $192,442,000 | 1.41% |
Frazier Life Sciences Management, L.P. | 203,684 | $14,802,000 | 1.26% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $8,098,000 | 1.22% |
Merlin Capital, Inc | 11,575 | $841,000 | 1.11% |